Drug Class
Sympathomimetic
Pharmacology
A naturally occurring catecholamine which primarily acts on Alpha & Beta adrenergic receptors. This = increase in HR, increase in the force of myocardial contraction, increase in irritability of the ventricles, bronchodilation & peripheral vasoconstriction.
Metabolism
Majority metabolised by sympathetic nerve endings. It’s subject to the process of mitochondrial enzymatic breakdown of monoamine oxidase at synaptic level
Indications
Contraindications
Nil
Precautions
Side effects
Presentation
Onset
Duration
IV 30sec
IM 60sec
5-10min
Adult Dosages
Cardiac arrest
• IV 1mg, repeated at 3-5mins, no max dose
Anaphylaxis OR severe allergic reaction
• IM 500mcg, repeated at 5mins, no max dose
• NEB 5mg, single dose only
Severe life-threatening bronchospasm OR silent chest
• IM 500mcg, repeated at 5mins, no max dose
Paediatric dosages
Cardiac arrest IV • ≥10kg or 1yr - 10mcg/kg • <10kg (excl. newly born) - 100mcg • Newly born - 50mcg Repeated at 3-5min, no max dose
Anaphylaxis OR severe allergic reaction IM • ≥6years ‐ 300mcg • 1-6yrs - 150mcg • 6mo-1yr - 100mcg • <6mo - 50mcg * Repeated at5minuteintervals. No max dose. NEB • 5mg, single dose only * May be admin for upper airway obstruction throught to allergic in origin but IM adrenaline must also be used
Severe life-threatening bronchospasm OR silent chest (single words AND/OR haemodynamic compromise AND/OR ALOC)
IM
• ≥6years ‐ 300mcg
• 1-6yrs - 150mcg
• 6mo-1yr - 100mcg
• <6mo - 50mcg
* Repeated at5minuteintervals. No max dose.
Croup (moderate to severe)
NEB
• 5mg, single dose only